Atherosclerosis

Hypothesis: is soluble P-selectin a new marker of platelet activation?
pp. 135-138(4)
Authors: Blann A.D.; Lip G.Y.H.

Effects of low-dose pravastatin sodium on plasma cholesterol levels and aortic atherosclerosis of heterozygous WHHL rabbits fed a low cholesterol (0.03%) enriched diet for one year
pp. 139-147(9)
Authors: Harsch M.; Braesen J.H.; Niendorf A.

Aortic medial necrosis with or without thrombosis in rabbits treated with Russell's viper venom and angiotensin II
pp. 149-156(8)
Authors: Nakamura M.; Abe S.; Kinukawa N.

Expression of vascular cell adhesion molecule-1 (VCAM-1) in the aortae of hypercholesterolemic rabbits with high (HAR) and low (LAR) atherosclerotic response
pp. 157-164(8)
Authors: Teupser D.; Thiery J.; Haas U.; Stein O.; Stein Y.; Seidel D.

Heterozygous hepatic lipase deficiency, due to two missense mutations R186H and L334F, in the HL gene
pp. 165-174(10)
Authors: Knudsen P.; Antikainen M.; Uusi-Oukari M.; Ehnholm S.; Lahdenpera S.; Bensadoun A.; Funke H.; Wiebusch H.; Assmann G.; Taskinen M.-R.; Ehnholm C.

Growth hormone therapy transiently increases apolipoprotein(a) in short -thalassaemia major children with normal growth hormone reserve
pp. 175-182(8)
Authors: Tam S.C.F.; Pang R.W.C.; Janus E.D.; Kwan E.Y.W.; Low L.C.K.

The MspI polymorphism of the apolipoprotein A-II gene as a modulator of the dyslipidemic state found in visceral obesity
pp. 183-190(8)
Authors: Vohl M.-C.; Lamarche B.; Bergeron J.; Moorjani S.; Prud'homme D.; Nadeau A.; Tremblay A.; Lupien P.J.; Bouchard C.; Despres J.-P.

Screening of the 3' two-thirds of the coding area of the apo B gene in Finnish hypercholesterolemic patients - Report of six new genetic variants
pp. 191-199(9)
Authors: Ilmonen M.; Ebeling T.; Viikari J.; Ojala J.-P.; Tikkanen M.J.

The prevalence of insulin resistance and other cardiovascular disease risk factors in healthy elderly southwestern nigerians
pp. 201-211(11)
Authors: Ezenwaka C.E.; Akanji A.O.; Akanji B.O.; Unwin N.C.; Adejuwon C.A.

In vivo metabolism of apo A-I and apo A-II in subjects with apo A-I(Lys₁₀₇->0) associated with reduced HDL cholesterol and Lp(AI w AII) deficiency
pp. 213-222(10)
Authors: Tilly-Kiesi M.; Packard C.J.; Kahri J.; Ehnholm C.; Shepherd J.; Taskinen M.-R.

Characterization of the genetic elements controlling lipoprotein(a) concentrations in Mexican Americans. Evidence for at least three controlling elements linked to LPA, the locus encoding apolipoprotein(a)
pp. 223-233(11)
Authors: Rainwater D.L.; Kammerer C.M.; VandeBerg J.L.; Hixson J.E.

Relationship of serum ferritin concentrations with metabolic cardiovascular risk factors in men without evidence for coronary artery disease
pp. 235-240(6)
Authors: Halle M.; Konig D.; Berg A.; Keul J.; Baumstark M.W.

Peripheral vasoactivity in familial hypercholesterolemic subjects treated with heparin-induced extracorporeal LDL precipitation (HELP)
pp. 241-249(9)
Authors: Stadler R.W.; Ibrahim S.F.; Lees R.S.

BAYw6228 suppresses accumulation of macrophages in balloon-induced intimal thickening of rabbit carotid artery
pp. 251-254(4)
Authors: Igarashi M.; Takeda Y.; Mori S.; Ishibashi N.; Komatsu E.; Takahashi K.; Fuse T.; Yamamura M.; Sugiyama Y.; Saito Y.